SMPDL3B and diabetic kidney disease: FSGS and DKD (diabetic kidney disease) have elevated levels of circulating soluble urokinase plasminogen activator receptor (suPAR) but the podocyte expression of acid sphingomyelinase-like phosphodiesterase 3b (SMPDL3b) is elevated only in DKD (105).